Literature DB >> 28637870

Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.

Beth A Rose1, Tomohiro Yokota1,2, Vishnu Chintalgattu3, Shuxun Ren1, Luisa Iruela-Arispe4, Aarif Y Khakoo3, Susumu Minamisawa2,5, Yibin Wang6.   

Abstract

Stress-induced p38 mitogen-activated protein kinase (MAPK) activity is implicated in pathological remodeling in the heart. For example, constitutive p38 MAPK activation in cardiomyocytes induces pathological features, including myocyte hypertrophy, apoptosis, contractile dysfunction, and fetal gene expression. However, the physiological function of cardiomyocyte p38 MAPK activity in beneficial compensatory vascular remodeling is unclear. This report investigated the functional role and the underlying mechanisms of cardiomyocyte p38 MAPK activity in cardiac remodeling induced by chronic stress. Using both in vitro and in vivo model systems, we found that p38 MAPK activity is required for hypoxia-induced pro-angiogenic activity from cardiomyocytes and that p38 MAPK activation in cardiomyocyte is sufficient to promote paracrine signaling-mediated, pro-angiogenic activity. We further demonstrate that VEGF is a paracrine factor responsible for the p38 MAPK-mediated pro-angiogenic activity from cardiomyocytes and that p38 MAPK pathway activation is sufficient for inducing VEGF secretion from cardiomyocytes in an Sp1-dependent manner. More significantly, cardiomyocyte-specific inactivation of p38α in mouse heart impaired compensatory angiogenesis after pressure overload and promoted early onset of heart failure. In summary, p38αMAPK has a critical role in the cross-talk between cardiomyocytes and vasculature by regulating stress-induced VEGF expression and secretion in cardiomyocytes. We conclude that as part of a stress-induced signaling pathway, p38 MAPK activity significantly contributes to both pathological and compensatory remodeling in the heart.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  angiogenesis; cardiac hypertrophy; cardiomyocyte; cross-talk; p38 MAPK; vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2017        PMID: 28637870      PMCID: PMC5546022          DOI: 10.1074/jbc.M117.784553

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

Authors:  Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

2.  The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase.

Authors:  M Hoshijima; V P Sah; Y Wang; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1998-03-27       Impact factor: 5.157

3.  Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).

Authors:  Sudhir Singh; Ronda L Simpson; Robert G Bennett
Journal:  J Biol Chem       Date:  2014-11-11       Impact factor: 5.157

Review 4.  MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.

Authors:  Bozena Kaminska
Journal:  Biochim Biophys Acta       Date:  2005-09-08

5.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

6.  p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.

Authors:  Kazuhiko Nishida; Osamu Yamaguchi; Shinichi Hirotani; Shungo Hikoso; Yoshiharu Higuchi; Tetsuya Watanabe; Toshihiro Takeda; Soh Osuka; Takashi Morita; Gen Kondoh; Yoshihiro Uno; Kazunori Kashiwase; Masayuki Taniike; Atsuko Nakai; Yasushi Matsumura; Jun-ichi Miyazaki; Tatsuhiko Sudo; Kenichi Hongo; Yoichiro Kusakari; Satoshi Kurihara; Kenneth R Chien; Junji Takeda; Masatsugu Hori; Kinya Otsu
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  A cyclin D2-Rb pathway regulates cardiac myocyte size and RNA polymerase III after biomechanical stress in adult myocardium.

Authors:  Ekaterini Angelis; Alejandro Garcia; Shing S Chan; Katja Schenke-Layland; Shuxen Ren; Sarah J Goodfellow; Maria C Jordan; Kenneth P Roos; Robert J White; W Robb MacLellan
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

Review 8.  Current insights on the biology and clinical aspects of VEGF regulation.

Authors:  Daniel M Birk; Joel Barbato; Leila Mureebe; Rabih A Chaer
Journal:  Vasc Endovascular Surg       Date:  2008-09-17       Impact factor: 1.089

9.  Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1.

Authors:  G L Wang; B H Jiang; G L Semenza
Journal:  Biochem Biophys Res Commun       Date:  1995-11-13       Impact factor: 3.575

10.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

View more
  10 in total

1.  p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart.

Authors:  Tomohiro Yokota; Jin Li; Jijun Huang; Zhaojun Xiong; Qing Zhang; Tracey Chan; Yichen Ding; Christoph Rau; Kevin Sung; Shuxun Ren; Rajan Kulkarni; Tzung Hsiai; Xinshu Xiao; Marlin Touma; Susumu Minamisawa; Yibin Wang
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

2.  Non-neuronal cardiac acetylcholine system playing indispensable roles in cardiac homeostasis confers resiliency to the heart.

Authors:  Shino Oikawa; Yuko Kai; Asuka Mano; Hisayuki Ohata; Atsushi Kurabayashi; Masayuki Tsuda; Yoshihiko Kakinuma
Journal:  J Physiol Sci       Date:  2021-01-18       Impact factor: 2.781

3.  Intravenous injection of extracellular vesicles to treat chronic myocardial ischemia.

Authors:  Laura A Scrimgeour; Brittany A Potz; Ahmad Aboul Gheit; Yuhong Liu; Guangbin Shi; Melissa Pfeiffer; Bonnie J Colantuono; Neel R Sodha; M Ruhul Abid; Frank W Sellke
Journal:  PLoS One       Date:  2020-09-11       Impact factor: 3.240

4.  Receptor tyrosine kinase inhibitors negatively impact on pro-reparative characteristics of human cardiac progenitor cells.

Authors:  Andrew J Smith; Prashant Ruchaya; Robert Walmsley; Kathleen E Wright; Fiona C Lewis-McDougall; Jacquelyn Bond; Georgina M Ellison-Hughes
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

5.  MicroRNA-135a-3p regulates angiogenesis and tissue repair by targeting p38 signaling in endothelial cells.

Authors:  Basak Icli; Winona Wu; Denizhan Ozdemir; Hao Li; Stefan Haemmig; Xin Liu; Giorgio Giatsidis; Henry S Cheng; Seyma Nazli Avci; Merve Kurt; Nathan Lee; Raphael Boesche Guimaraes; Andre Manica; Julio F Marchini; Stein Erik Rynning; Ivar Risnes; Ivana Hollan; Kevin Croce; Dennis P Orgill; Mark W Feinberg
Journal:  FASEB J       Date:  2019-01-22       Impact factor: 5.191

Review 6.  The application of big data to cardiovascular disease: paths to precision medicine.

Authors:  Jane A Leopold; Bradley A Maron; Joseph Loscalzo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

7.  Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury.

Authors:  Kantapich Kongpol; Nitirut Nernpermpisooth; Eakkapote Prompunt; Sarawut Kumphune
Journal:  Biomolecules       Date:  2019-10-31

Review 8.  VEGF-A in Cardiomyocytes and Heart Diseases.

Authors:  Mariantonia Braile; Simone Marcella; Leonardo Cristinziano; Maria Rosaria Galdiero; Luca Modestino; Anne Lise Ferrara; Gilda Varricchi; Giancarlo Marone; Stefania Loffredo
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

9.  Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.

Authors:  Katharina Bottermann; Lisa Kalfhues; Rianne Nederlof; Anne Hemmers; Lucia M Leitner; Vici Oenarto; Jana Nemmer; Mirjam Pfeffer; Vidisha Raje; Rene Deenen; Patrick Petzsch; Heba Zabri; Karl Köhrer; Andreas S Reichert; Maria Grandoch; Jens W Fischer; Diran Herebian; Johannes Stegbauer; Thurl E Harris; Axel Gödecke
Journal:  Basic Res Cardiol       Date:  2022-10-07       Impact factor: 12.416

10.  Analysis of extracellular vesicle miRNA profiles in heart failure.

Authors:  Jae Gyun Oh; Philyoung Lee; Ronald E Gordon; Susmita Sahoo; Changwon Kho; Dongtak Jeong
Journal:  J Cell Mol Med       Date:  2020-06-02       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.